Literature DB >> 14708681

Hepatitis B vaccines.

Daniel Shouval1.   

Abstract

Yeast-derived hepatitis B vaccines, containing the small HBV envelope protein SHBAg, are immunogenic, safe and cost-effective in prevention of hepatitis B virus infection in neonates, children and adults. Newly developed pre-S/S hepatitis B vaccines may play a role in inducing fast and augmented seroconversion rates in special risk groups.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14708681     DOI： 10.1016/s0168-8278(03)00152-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


  32 in total

1.  Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

Authors:  I Desombere; T Cao; Y Gijbels; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  Screening and cloning for proteins transactivated by the PS1TP5 protein of hepatitis B virus: a suppression subtractive hybridization study.

Authors:  Jian-Kang Zhang; Long-Feng Zhao; Jun Cheng; Jiang Guo; Dan-Qiong Wang; Yuan Hong; Yu Mao
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

3.  A new vaccine escape mutant of hepatitis B virus causes occult infection.

Authors:  Qing Ye; Shi-Qiang Shang; Wei Li
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Induced immunity against hepatitis B virus.

Authors:  Zeinab Nabil Ahmed Said; Kouka Saadeldin Abdelwahab
Journal:  World J Hepatol       Date:  2015-06-28

Review 5.  Vaccination strategies in patients with IBD.

Authors:  Javier P Gisbert; María Chaparro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

6.  Reactivation of hepatitis B: pathogenesis and clinical implications.

Authors:  Anthony Post; Shweta Nagendra
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

Review 7.  Efficacy of the vaccination in inflammatory bowel disease.

Authors:  Elisa Carrera; Rebeca Manzano; Elena Garrido
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

8.  Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study.

Authors:  L Bracciale; M Fabbiani; A Sansoni; L Luzzi; L Bernini; G Zanelli
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

9.  A pilot clinical trial of a recombinant ricin vaccine in normal humans.

Authors:  Ellen S Vitetta; Joan E Smallshaw; Elaine Coleman; Hasan Jafri; Callie Foster; Robert Munford; John Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy.

Authors:  Jaswinder Singh Sodhi; Wasim Raja; Showkat Ali Zargar; Abid Showkat; Shaheena Parveen; Syed Nisar; Manzoor Ahmad Wani; Gul Javid; Mushtaq Khan; Sheikh Aejaz; Gul Mohd; Aleem Jan; Gh Nabi Yattoo; Altaf Shah; Gh Mohd Gulzar; Rashid Lone
Journal:  Indian J Gastroenterol       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.